Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 138

1.

[Phenotype and genetic analysis of a pedigree affected with progressive familial intrahepatic cholestasis].

Wu Q, Ma B, Yang S, Mei S, Ma X, Kong X, Shi H.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2019 Aug 10;36(8):789-793. doi: 10.3760/cma.j.issn.1003-9406.2019.08.009. Chinese.

PMID:
31400129
2.

Association between bile salt export pump polymorphisms and intrahepatic cholestasis of pregnancy susceptibility: a meta-analysis of case-control studies.

Zhou J, Yao Y, Huang X, Chen D, Zhang T, Zhang Y.

Gynecol Endocrinol. 2019 Feb;35(2):179-183. doi: 10.1080/09513590.2018.1512570. Epub 2019 Jan 6.

PMID:
30614300
3.

Functional analysis of the correlation between ABCB11 gene mutation and primary intrahepatic stone.

Gan L, Pan S, Cui J, Bai J, Jiang P, He Y.

Mol Med Rep. 2019 Jan;19(1):195-204. doi: 10.3892/mmr.2018.9661. Epub 2018 Nov 15.

4.

Clinical phenotype and molecular analysis of a homozygous ABCB11 mutation responsible for progressive infantile cholestasis.

Imagawa K, Hayashi H, Sabu Y, Tanikawa K, Fujishiro J, Kajikawa D, Wada H, Kudo T, Kage M, Kusuhara H, Sumazaki R.

J Hum Genet. 2018 May;63(5):569-577. doi: 10.1038/s10038-018-0431-1. Epub 2018 Mar 5. Review.

PMID:
29507376
5.

Comprehensive bile acid profiling in hereditary intrahepatic cholestasis: Genetic and clinical correlations.

Liu T, Wang RX, Han J, Hao CZ, Qiu YL, Yan YY, Li LT, Wang NL, Gong JY, Lu Y, Zhang MH, Xie XB, Yang JC, You YJ, Li JQ, Knisely AS, Borchers CH, Ling V, Wang JS.

Liver Int. 2018 Sep;38(9):1676-1685. doi: 10.1111/liv.13714. Epub 2018 Mar 12.

PMID:
29412511
6.

Partial external biliary diversion in bile salt export pump deficiency: Association between outcome and mutation.

Ellinger P, Stindt J, Dröge C, Sattler K, Stross C, Kluge S, Herebian D, Smits SHJ, Burdelski M, Schulz-Jürgensen S, Ballauff A, Schulte Am Esch J, Mayatepek E, Häussinger D, Kubitz R, Schmitt L.

World J Gastroenterol. 2017 Aug 7;23(29):5295-5303. doi: 10.3748/wjg.v23.i29.5295.

7.

A Rare BSEP Mutation Associated with a Mild Form of Progressive Familial Intrahepatic Cholestasis Type 2.

Waisbourd-Zinman O, Surrey LF, Schwartz AE, Russo PA, Wen J.

Ann Hepatol. 2017 May - Jun;16(3):465-468. doi: 10.5604/16652681.1235494.

8.
9.

 Bile salt export pump deficiency disease: two novel, late onset, ABCB11 mutations identified by next generation sequencing.

Vitale G, Pirillo M, Mantovani V, Marasco E, Aquilano A, Gamal N, Francalanci P, Conti F, Andreone P.

Ann Hepatol. 2016 Sep-Oct;15(5):795-800. doi: 10.5604/16652681.1212618.

10.

Analysis of the Bile Salt Export Pump (ABCB11) Interactome Employing Complementary Approaches.

Przybylla S, Stindt J, Kleinschrodt D, Schulte Am Esch J, Häussinger D, Keitel V, Smits SH, Schmitt L.

PLoS One. 2016 Jul 29;11(7):e0159778. doi: 10.1371/journal.pone.0159778. eCollection 2016.

11.

Clinical and ABCB11 profiles in Korean infants with progressive familial intrahepatic cholestasis.

Park JS, Ko JS, Seo JK, Moon JS, Park SS.

World J Gastroenterol. 2016 May 28;22(20):4901-7. doi: 10.3748/wjg.v22.i20.4901.

12.

Disruption of BSEP Function in HepaRG Cells Alters Bile Acid Disposition and Is a Susceptive Factor to Drug-Induced Cholestatic Injury.

Qiu X, Zhang Y, Liu T, Shen H, Xiao Y, Bourner MJ, Pratt JR, Thompson DC, Marathe P, Humphreys WG, Lai Y.

Mol Pharm. 2016 Apr 4;13(4):1206-16. doi: 10.1021/acs.molpharmaceut.5b00659. Epub 2016 Mar 8.

PMID:
26910619
13.

No contribution of the ABCB11 p.444A polymorphism in Japanese patients with drug-induced cholestasis.

Kagawa T, Hirose S, Arase Y, Oka A, Anzai K, Tsuruya K, Shiraishi K, Orii R, Ieda S, Nakazawa T, Tomita K, Hokari R, Miura S, Ebinuma H, Saito H, Kitamura T, Horie Y, Okuse C, Wasada M, Inoko H, Tohkin M, Saito Y, Maekawa K, Takikawa H, Mine T.

Drug Metab Dispos. 2015 May;43(5):691-7. doi: 10.1124/dmd.114.061325. Epub 2015 Feb 23.

PMID:
25713208
14.

The association between bile salt export pump single-nucleotide polymorphisms and primary biliary cirrhosis susceptibility and ursodeoxycholic acid response.

Chen RR, Li YJ, Zhou XM, Wang L, Xing J, Han S, Cui LN, Zheng LH, Wu KC, Shi YQ, Han ZY, Han Y, Fan DM.

Dis Markers. 2014;2014:350690. doi: 10.1155/2014/350690. Epub 2014 Oct 19.

15.

Bile salt export pump: a sensitive and specific immunohistochemical marker of hepatocellular carcinoma.

Lagana SM, Salomao M, Remotti HE, Knisely AS, Moreira RK.

Histopathology. 2015 Mar;66(4):598-602. doi: 10.1111/his.12601. Epub 2015 Jan 23.

PMID:
25378077
16.

Current Concepts in Drug-Induced Bile Salt Export Pump (BSEP) Interference.

Kenna JG.

Curr Protoc Toxicol. 2014 Aug 7;61:23.7.1-15. doi: 10.1002/0471140856.tx2307s61.

PMID:
25104267
17.

Liver transcript analysis reveals aberrant splicing due to silent and intronic variations in the ABCB11 gene.

Davit-Spraul A, Oliveira C, Gonzales E, Gaignard P, Thérond P, Jacquemin E.

Mol Genet Metab. 2014 Nov;113(3):225-9. doi: 10.1016/j.ymgme.2014.07.006. Epub 2014 Jul 15.

PMID:
25085279
18.

Diagnosis of ABCB11 gene mutations in children with intrahepatic cholestasis using high resolution melting analysis and direct sequencing.

Hu G, He P, Liu Z, Chen Q, Zheng B, Zhang Q.

Mol Med Rep. 2014 Sep;10(3):1264-74. doi: 10.3892/mmr.2014.2349. Epub 2014 Jun 20.

19.

Differential roles of ubiquitination in the degradation mechanism of cell surface-resident bile salt export pump and multidrug resistance-associated protein 2.

Aida K, Hayashi H, Inamura K, Mizuno T, Sugiyama Y.

Mol Pharmacol. 2014 Mar;85(3):482-91. doi: 10.1124/mol.113.091090. Epub 2013 Dec 30.

PMID:
24378332
20.

The role of bile salt export pump gene repression in drug-induced cholestatic liver toxicity.

Garzel B, Yang H, Zhang L, Huang SM, Polli JE, Wang H.

Drug Metab Dispos. 2014 Mar;42(3):318-22. doi: 10.1124/dmd.113.054189. Epub 2013 Dec 12.

Supplemental Content

Support Center